Therapeutic interventions targeting NGF/BDNF–Trk and neural co−regulatory pathways in osteosarcoma immunity: targets, mechanistic rationale, pharmacodynamic biomarkers, and combination strategies. This evidence concerns the gene NTRK1 and osteosarcoma.